Dr. Gottlieb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Union Sq E
New York, NY 10003Phone+1 212-844-8800
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Dermatology, 1990 - 1993
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1982 - 1984
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1980 - 1982
- Weill Cornell MedicineClass of 1980
- Rockefeller UniversityPh.D., Immunology, 1979
- Brandeis UniversityB.A., Summa Cum Laude, 1969 - 1973
Certifications & Licensure
- NY State Medical License 1981 - 2026
- CT State Medical License 1988 - 2024
- MA State Medical License 2006 - 2018
- NJ State Medical License 1995 - 2011
- American Board of Dermatology Dermatology
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL 2 study.Kenneth B Gordon, Matthias Augustin, Jonathan Barker, Yayoi Tada, Mark G Lebwohl
Journal of the American Academy of Dermatology. 2025-03-07 - Effect of Bimekizumab on Patient-Reported Outcomes and Work Productivity in Patients With Psoriatic Arthritis: 1-Year Results From 2 Phase III Studies.Dafna D Gladman, Philip J Mease, Laure Gossec, M Elaine Husni, Alice B Gottlieb
The Journal of Rheumatology. 2025-03-01 - Validation of DermSat-7 for Assessing Treatment Satisfaction in Patients With Psoriasis.April W Armstrong, Kathryn Lee, Danielle Yee, Michael Woodbury, Melissa Zundell
JAMA Dermatology. 2025-02-26
Press Mentions
- JDD in the News: Benefits of Long-Term Ixekizumab in Psoriasis; Secukinumab in Psoriasis Patients with Skin of ColorSeptember 19th, 2024
- Dr. Alice Gottlieb to Present Hidradenitis Suppurativa Findings at American Academy of Dermatology Annual MeetingJanuary 28th, 2019
- Stelara OK'd for Psoriatic ArthritisOctober 4th, 2013
Grant Support
- Immunological Mechanisms In PsoriasisNational Center For Research Resources1988–1990
- Immunopathogenesis Of Psoriasis And Psoriatic ArthritisNational Center For Research Resources1987
- Monoclonal Probes Of Epidermal DifferentiationNational Center For Research Resources1987
- Cross Reactivity Of Anti-Lymphocyte Antibodies With Human Epidermal CellsNational Center For Research Resources1985–1986
Professional Memberships
- Fellow
- Fellow
External Links
- YouTubehttps://www.youtube.com/embed/6kXBz5wHoJ8
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: